Literature DB >> 21094956

Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.

Oak Z Chi1, Christine Hunter, Xia Liu, Youngchan Chi, Harvey R Weiss.   

Abstract

In cerebral ischemia, transmission by the inhibitory neurotransmitter, γ-aminobutyric acid (GABA) is altered. This study was performed to determine whether blockade of GABA(A) receptor would affect regional cerebral blood flow (rCBF) and blood-brain barrier (BBB) permeability in a focal ischemic area of the brain. Rats were anesthetized with isoflurane and mechanically ventilated. Fifteen minutes after a permanent middle cerebral artery (MCA) occlusion, one half of the rats were infused with bicuculline 1mg/kg/min iv for 2 min followed by 0.1mg/kg/min iv to the end of the experiment. The other half were infused with normal saline. At one hour after MCA occlusion, rCBF was determined using ¹⁴C-iodoantipyrine and BBB permeability was determined by measuring the transfer coefficient (Ki) of ¹⁴C-α-aminoisobutyric acid. With MCA occlusion, rCBF was decreased in the ischemic cortex (IC) (-70%) in the control rats. In the bicuculline treated rats, the rCBF of the IC was lower (-48%) than the contralateral cortex but higher than the rCBF of the IC of the control rats (+55%). MCA occlusion increased Ki in the IC of the control rats (+72%) and bicuculline administration increased Ki further (+53%) in the IC. Blockade of GABA(A) receptors did not significantly affect rCBF or BBB permeability in the non-ischemic brain regions under isoflurane anesthesia. Our data demonstrated that blockade of GABA(A) receptors increased rCBF and enhanced the BBB disruption in focal cerebral ischemia. Our data suggest that GABA(A) receptors are involved, at least in part, in modulating rCBF and BBB disruption in focal cerebral ischemia.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094956     DOI: 10.1016/j.jns.2010.10.024

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years.

Authors:  Sylvie Mesrine; Gaëlle Gusto; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Agnès Fournier
Journal:  Eur J Clin Pharmacol       Date:  2018-07-04       Impact factor: 2.953

2.  Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer.

Authors:  Daniel J Crona; Young E Whang
Journal:  Invest New Drugs       Date:  2014-12-03       Impact factor: 3.850

Review 3.  Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

Authors:  Jia Liu; Lu-Ning Wang; Xin Ma; Xunming Ji
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

Review 4.  Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review.

Authors:  Neha Dhir; Bikash Medhi; Ajay Prakash; Manoj Kumar Goyal; Manish Modi; Sandeep Mohindra
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

5.  Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

Authors:  Jia Liu; Jing Zhang; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30

6.  Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.

Authors:  Pablo Cisternas; Xavier Taylor; Abigail Perkins; Orlando Maldonado; Elysabeth Allman; Ricardo Cordova; Yamil Marambio; Braulio Munoz; Taylor Pennington; Shunian Xiang; Jie Zhang; Ruben Vidal; Brady Atwood; Cristian A Lasagna-Reeves
Journal:  Aging Cell       Date:  2020-09-10       Impact factor: 11.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.